Back to Search
Start Over
Dosimetric and clinical analysis of pseudo-progression versus recurrence after hypo-fractionated radiotherapy for brain metastases
- Source :
- Radiation Oncology, Vol 18, Iss 1, Pp 1-13 (2023)
- Publication Year :
- 2023
- Publisher :
- BMC, 2023.
-
Abstract
- Abstract Background The main challenge in follow-up duration of patients with brain metastases after stereotactic radiotherapy is to distinguish between pseudo-progression and tumor recurrence. The objective of this study is to retrospectively analyze the predictive factors. Methods The study included 123 patients with enlarged brain metastases after hypo-fractionated radiotherapy in our center from March 2009 to October 2019, and the baseline clinical features, radiotherapy planning parameters, and enhanced magnetic resonance imaging before and after radiation therapy were analyzed. Logistic regression was performed to compare the differences between groups. Independent risk factors with P
Details
- Language :
- English
- ISSN :
- 1748717X
- Volume :
- 18
- Issue :
- 1
- Database :
- Directory of Open Access Journals
- Journal :
- Radiation Oncology
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.75239fae336640fd82d5a6d7ae4b0e59
- Document Type :
- article
- Full Text :
- https://doi.org/10.1186/s13014-023-02214-7